Immune responses to bioengineered organs. Issue 1 (February 2017)

• Record Type: Journal Article
• Authors: Ochando, Jordi; Charron, Dominique; Baptista, Pedro M.; Uygun, Basak E.
• Is Part Of: Current opinion in organ transplantation. Volume 22:Issue 1(2017:Feb.)
• Page Start: 79
• Page End: 85
• Publication Date: 2017-02
• Subjects: allogeneicity -- bioengineered organs -- extracellular matrix -- stem cells; Transplantation of organs, tissues, etc -- Periodicals; Immunosuppression -- Periodicals; Transplantation immunology -- Periodicals; 617.954
• DOI: 10.1097/MOT.0000000000000378
• Languages: English
• ISSNs: 1087-2418

Abstract

Abstract : Purpose of review: Organ donation in the United States registered 9079 deceased organ donors in 2015. This high percentage of donations allowed organ transplantation in 29 851 recipients. Despite increasing numbers of transplants performed in comparison with previous years, the numbers of patients that are in need for a transplant increase every year at a higher rate. This reveals that the discrepancy between the demand and availability of organs remains fundamental problem in organ transplantation. Recent findings: Development of bioengineered organs represents a promising approach to increase the pool of organs for transplantation. The technology involves obtaining complex three-dimensional scaffolds that support cellular activity and functional remodeling though tissue recellularization protocols using progenitor cells. This innovative approach integrates cross-thematic approaches from specific areas of transplant immunology, tissue engineering and stem cell biology, to potentially manufacture an unlimited source of donor organs for transplantation. Summary: Although bioengineered organs are thought to escape immune recognition, the potential immune reactivity toward each of its components has not been studied in detail. Here, we summarize the host immune response toward different progenitor cells and discuss the potential implications of using nonself biological scaffolds to develop bioengineered organs.